Literature DB >> 1587864

A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.

M E Meyer1, C Quirin-Stricker, T Lerouge, M T Bocquel, H Gronemeyer.   

Abstract

The two transcription activation functions (TAFs) of the human progesterone receptor (hPR) have been characterized. TAF-1, located in the N-terminal region A/B, has been narrowed down to a 91-amino acid sequence, which is sufficient for transcription activation in chimeras with the GAL4 DNA binding domain. Both hPR TAF-1 and TAF-2 activate a minimal promoter in yeast. No autonomous TAF could be found in the N-terminal 164 amino acids (designated AB3) which are responsible for the differential activation of promoters by the hPR isoforms A and B. Reduction of the target gene promoter complexity did not alter this differential activation, indicating that AB3 does not require additional promoter-bound factors to exert its effect. Instead, the cell specificity of AB3 and its ability to squelch hPR-induced transcription suggest that this differential isoform activity is due to the effect of a limiting factor which binds to region AB3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587864

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 2.  Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms.

Authors:  Orla M Conneely; Biserka M Jericevic
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

3.  Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.

Authors:  Raj Kumar; Carmen M Moure; Shagufta H Khan; Celetta Callaway; Sandra L Grimm; Devrishi Goswami; Patrick R Griffin; Dean P Edwards
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 4.  The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk.

Authors:  Valerie A Flores; Hugh S Taylor
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06-23       Impact factor: 4.741

Review 5.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

6.  Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function.

Authors:  Keith D Connaghan-Jones; Aaron F Heneghan; Michael T Miura; David L Bain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

Review 7.  Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.

Authors:  Nicole L Moore; Ramesh Narayanan; Nancy L Weigel
Journal:  Steroids       Date:  2007-01-04       Impact factor: 2.668

8.  The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.

Authors:  D X Wen; Y F Xu; D E Mais; M E Goldman; D P McDonnell
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors:  Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2009-12-11

10.  Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.

Authors:  F De Amicis; S Zupo; M L Panno; R Malivindi; F Giordano; I Barone; L Mauro; S A W Fuqua; S Andò
Journal:  Mol Endocrinol       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.